Alfar, Baby Boy .
HRN: 26-69-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/24/2025
03/02/2025
IV
46
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes